Neurophoenix
Neurophoenix is a biopharmaceutical company developing a new therapeutic solution for optic neuropathies.
Neurophoenix operates in biotechnology based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2018.
Its activity falls under biotechnology; the profile below is assembled from public directory data.
The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Private company.
| Sector | Biotechnology |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2018 |
| Stage | Private company |
Website: www.neurophoenix.fr
Browse related
Sign in to view the contact information we hold for Neurophoenix.
Create a free account
Create a free account